| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $310.0M | — | +17.3% |
| Cost of Revenue | $263.3M | — | +18.2% |
| R&D Expense | $5.5M | — | +11.6% |
| SG&A Expense | $13.5M | — | -23.0% |
| Operating Income | $22.4M | — | — |
| Interest Expense | $2.2M | — | -18.5% |
| Pre-tax Income | $20.5M | — | +962.3% |
| Income Tax | $6.5M | — | — |
| Net Income | $11.5M | — | +688.7% |
| EPS (Basic) | $0.21 | — | +625.0% |
| EPS (Diluted) | $0.21 | — | +625.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $26.1M | -44.4% | -59.0% |
| Accounts Receivable | $133.8M | +8.8% | +16.5% |
| Current Assets | $165.2M | -5.3% | -9.5% |
| Total Assets | $367.7M | -4.2% | +53.2% |
| Current Liabilities | $113.2M | -23.4% | +3.4% |
| Long-term Debt | $163.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.6M | — | -106.6% |
| Capital Expenditures | $42K | — | -26.3% |
| Investing Cash Flow | -$42K | — | +26.3% |
| Financing Cash Flow | -$19.2M | — | -474.1% |
| Free Cash Flow | -$1.6M | — | -106.8% |
| +2.0% |
| Total Liabilities | $396.8M | -3.9% | +41.1% |
| Stockholders' Equity | $1.9M | -53.9% | -75.8% |